Liver Sarcoidosis with Unique MRI Images Using Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid

被引:0
|
作者
Wada, Nozomu [1 ,2 ]
Nouso, Kazuhiro [2 ]
Kariyama, Kazuya [1 ]
Wakuta, Akiko [1 ]
Kishida, Masayuki [1 ]
Nishimura, Mamoru [1 ]
Higashi, Toshihiro [1 ]
机构
[1] Okayama Citizens Hosp, Liver Dis Ctr, Okayama 7000833, Japan
[2] Okayama Univ Hosp, Dept Gastroenterol, Okayama 7008558, Japan
关键词
liver sarcoidosis; ursodeoxycholic acid (UDCA); gadolinium ethoxybenzyl diethylenetriamine; pentaacetic acid (Gd-EOB); CHRONIC HEPATITIS-C; GLUCOCORTICOID-RECEPTOR; URSODEOXYCHOLIC ACID; RAT HEPATOCYTES; ACTIVATION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Sarcoidosis is a systemic disease characterized by the formation of non-caseating granulomas in multiple organs. In the diagnosis of sarcoidosis, imaging modalities such as ultrasonography, computed tomography (CT) and magnetic resonance imaging (MRI) are useful; however, there are few reports of MRI imaging using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB) MRI. A 46-year-old Japanese female with suspected pulmonary sarcoidosis was admitted to our hospital because low-density mottles in the liver were observed incidentally by chest CT. The low-density mottles were not enhanced at the arterial phase or portal phase by abdominal CT and MRI, and decreased uptake was observed in the hepatobiliary phase of Gd-EOB MRI. No hematological disorder was observed except for a slight increase of biliary enzymes. The lesion was diagnosed as liver sarcoidosis by the liver biopsy. Since the patient refused steroid therapy, we prescribed ursodeoxycholic acid (UDCA). 600mg/day. The serum levels of biliary enzymes were normalized and the abdominal CT findings gradually improved after the initiation of UDCA medication. Gd-EOB MRI showed unique hypointense areas in the liver at the hepatobiliary phase, which might be useful in the diagnosis of liver sarcoidosis.
引用
收藏
页码:307 / 311
页数:5
相关论文
共 50 条
  • [1] Gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid interaction with clinical drugs in rats
    Kato, N
    Yokawa, T
    Tamura, A
    Heshiki, A
    Ebert, W
    Weinmann, HJ
    INVESTIGATIVE RADIOLOGY, 2002, 37 (12) : 680 - 684
  • [2] Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid
    Lin, Chun-Yi
    Chang, Wei-Chou
    Chou, Chen-Te
    Chen, Ran-Chou
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2015, 78 (11) : 666 - 672
  • [3] Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: Preliminary assessment
    Carlos, RC
    Hussain, HK
    Song, JH
    Francis, IR
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 179 (01) : 87 - 92
  • [4] Effects of Gadolinium-ethoxybenzyl-diethylenetriamine Pentaacetic Acid on T2-weighted MRCP
    Nakamura, Yuko
    Ohmoto, Toshifumi
    Saito, Tomoko
    Kajima, Toshio
    Nishimaru, Eiji
    Ito, Katsuhide
    MAGNETIC RESONANCE IN MEDICAL SCIENCES, 2009, 8 (04) : 143 - 148
  • [5] Estimation of liver function using T2* mapping on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging
    Katsube, Takashi
    Okada, Masahiro
    Kumano, Seishi
    Imaoka, Izumi
    Kagawa, Yuki
    Hori, Masatoshi
    Ishii, Kazunari
    Tanigawa, Noboru
    Imai, Yasuharu
    Kudo, Masatoshi
    Murakami, Takamichi
    EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (07) : 1460 - 1464
  • [6] Interstitial magnetic resonance lymphography using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid in rabbits with lymph node metastasis
    Tsuda, N
    Tsuji, T
    Kato, N
    INVESTIGATIVE RADIOLOGY, 2005, 40 (05) : 306 - 312
  • [7] Prediction of hepatocellular carcinoma in patients with Fontan-associated liver disease using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid magnetic resonance imaging
    Yamamoto, Atsushi
    Nagao, Michinobu
    Inoue, Akihiro
    Nakao, Risako
    Sakai, Reiko
    Nishina, Yu
    Morita, Satoru
    Sakai, Akiko
    Kogiso, Tomomi
    Kaneko, Koichiro
    Tokushige, Katsutoshi
    Inai, Kei
    Sakai, Shuji
    Yamaguchi, Junichi
    HEPATOLOGY RESEARCH, 2025, 55 (02) : 229 - 239
  • [8] Clinicopathological significance of the peritumoral decreased uptake area of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in hepatocellular carcinoma
    Nishie, Akihiro
    Asayama, Yoshiki
    Ishigami, Kousei
    Kakihara, Daisuke
    Nakayama, Tomohiro
    Ushijima, Yasuhiro
    Takayama, Yukihisa
    Shirabe, Ken
    Fujita, Nobuhiro
    Kubo, Yuichiro
    Hirakawa, Masakazu
    Honda, Hiroshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (03) : 561 - 567
  • [9] Hepatocellular carcinoma and focal nodular hyperplasia in patients with Fontan-associated liver disease: characterisation using dynamic gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MRI
    Shiina, Y.
    Inai, K.
    Sakai, R.
    Tokushige, K.
    Nagao, M.
    CLINICAL RADIOLOGY, 2023, 78 (03) : E197 - E203
  • [10] Distinguishing liver haemangiomas from metastatic tumours using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced diffusion-weighted imaging at 1.5T MRI
    Saito, Kazuhiro
    Yoshimura, Nobutaka
    Shirota, Natsuhiko
    Saguchi, Toru
    Sugimoto, Katsutoshi
    Tokuuye, Koichi
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2016, 60 (05) : 599 - 606